172 related articles for article (PubMed ID: 2515028)
1. The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.
Zhu PD; Luo HZ; Cheng J; Xu RH; Liu YF; Zheng WM; Song GY; Chen JH; Zhou ZH; Wu YM
Contraception; 1989 Nov; 40(5):591-604. PubMed ID: 2515028
[TBL] [Abstract][Full Text] [Related]
2. The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases.
Zhu PD; Luo HZ; Xu RH; Cheng J; Wu SC; Chen JH; Wu MZ; Wang XP
Contraception; 1989 Oct; 40(4):425-38. PubMed ID: 2510968
[TBL] [Abstract][Full Text] [Related]
3. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
Yin M; Zhu P; Luo H; Xu R
Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
[TBL] [Abstract][Full Text] [Related]
4. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
5. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural comparative study on endometrium of Chinese women using intrauterine devices of stainless steel ring, copper T220, and releasing levonorgestrel: morphometry of microvessels.
Wang JD; Zhu PD; Cheng J; Luo HZ; Xu RH; Hu WW
Contraception; 1990 Apr; 41(4):389-97. PubMed ID: 2335103
[TBL] [Abstract][Full Text] [Related]
8. Observation of the activity of factor VIII in the endometrium of women pre- and post-insertion of three types of IUDs.
Zhu PD; Luo HZ; Shi WL; Wang JD; Cheng J; Xu RH; Gu Z
Contraception; 1991 Oct; 44(4):367-84. PubMed ID: 1756625
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
10. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
12. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Videla-Rivero L; Etchepareborda JJ; Kesseru E
Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
[TBL] [Abstract][Full Text] [Related]
13. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device.
Luo H; Zhu P; Xu R; Cheng J; Zhao X; Wang JD
Anal Quant Cytol Histol; 1999 Oct; 21(5):409-12. PubMed ID: 10560523
[TBL] [Abstract][Full Text] [Related]
15. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
16. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
17. Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Heikkilä M
Contraception; 1982 Jun; 25(6):561-72. PubMed ID: 6811195
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
Baveja R; Bichille LK; Coyaji KJ; Engineer AD; Gogoi MP; Hazra MN; Kochhar M; Lahiri BC; Manuel M; Nanda UK
Contraception; 1989 Jan; 39(1):37-52. PubMed ID: 2491981
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
